In addition, patients with COVID-19 exhibited significantly less surface HLA-DR on CD8+ T cells than patients with influenza and trends toward less HLA-DR on CD4+ T cells in comparison to both patients with influenza and healthy controls (Fig. 1E). This evidence concerns the gene CD4 and COVID-19.